The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation
- 1 January 2007
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 26 (1) , 97-110
- https://doi.org/10.1377/hlthaff.26.1.97
Abstract
Using national survey data and risk equations from the Framingham Heart Study, we quantify the impact of antihypertensive therapy changes on blood pressures and the number and cost of heart attacks, strokes, and deaths. Antihypertensive therapy has had a major impact on health. Without it, 1999-2000 average blood pressures (at age 40+) would have been 10-13 percent higher, and 86,000 excess premature deaths from cardiovascular disease would have occurred in 2001. Treatment has generated a benefit-to-cost ratio of at least 6:1, but much more can be achieved. More effective use of antihypertensive medication would have an impact on mortality akin to eliminating all deaths from medical errors or accidents.Keywords
This publication has 17 references indexed in Scilit:
- Indications for and utilization of ACE inhibitors in older individuals with diabetesJournal of General Internal Medicine, 2006
- Hypertensive Therapy: Part IICirculation, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Is Technological Change In Medicine Worth It?Health Affairs, 2001
- Birth Cohort Evidence of Population Influences on Blood Pressure in the United States, 1887–1994Annals of Epidemiology, 2001
- Medical Care Expenditures for Selected Circulatory DiseasesMedical Care, 1999
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Lifetime Cost of Stroke in the United StatesStroke, 1996
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Termination from Medi-Cal — Does It Affect Health?New England Journal of Medicine, 1984